Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-2307
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study ; volume:475 ; number:5 ; day:22 ; month:7 ; year:2019 ; pages:563-571 ; date:11.2019
Virchows Archiv ; 475, Heft 5 (22.7.2019), 563-571, 11.2019
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00428-019-02624-7
- URN
-
urn:nbn:de:101:1-2020031514205110301802
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dottermusch, Matthias
- Krüger, Sandra
- Behrens, Hans-Michael
- Halske, Christine
- Röcken, Christoph
- SpringerLink (Online service)
Other Objects (12)
MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells
Clinicopathological significance of claudin-4 in gastric carcinoma
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Primary gastric adenosquamous carcinoma in a Caucasian woman: a case report
Couple Caucasian
Couple Caucasian
Caucasian perspectives
Couple Caucasian
Couple Caucasian
Couple Caucasian
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells
Clinicopathological significance of claudin-4 in gastric carcinoma
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Primary gastric adenosquamous carcinoma in a Caucasian woman: a case report
Couple Caucasian
Couple Caucasian
Caucasian perspectives
Couple Caucasian
Couple Caucasian
Couple Caucasian
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells
Clinicopathological significance of claudin-4 in gastric carcinoma
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Primary gastric adenosquamous carcinoma in a Caucasian woman: a case report
Couple Caucasian
Couple Caucasian
Caucasian perspectives
Couple Caucasian
Couple Caucasian
Couple Caucasian